Front-Line Treatment with Obinutuzumab +/- Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg

Yair Herishanu, Adir Shaulov, Riva Fineman, Sandra Basic-Kinda, Ariel Aviv, Ewa Wasik-Szczepanek, Ozren Jaksic, Mihnea Zdrenghea, Uri Greenbaum, Inga Mandac, Martin Simkovic, Marta Morawska, Ohad Benjamini, Martin Spacek, Anatoly Nemets, Osnat Bairey, Andrea Visentin, Rosa Ruchlemer, Luca Laurenti, Oana Stanca CiocanMichael Doubek, Lev Shvidel, Nagib Deli, Fatima Miras Calvo, Anne De Meuter, Maria Dimou, Francesca Romana Mauro, Marta Coscia, Horia Bumbea, Szasz Robert, Tamar Tadmor, Odit Gutwein, Massimo Gentile, Lydia Scarfo, Alessandra Tedeschi, Paolo Sportoletti, Eva Gimeno Vazquez, Juan Marquet Palomanes, Sarit Assouline, Maria Papaioannou, Andrei Breaster, Luciano Levato, Michael Gregor, Gian Matteo Rigolin, Javier Loscertales, Angeles Medina Perez, Marten R. Nijziel, Viola Maria Popov, Rosa Collado, Irma Slavutsky, Shai Levi, Aaron Polliack, Paolo Ghia

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
JournalBlood
Volume134
DOIs
StatePublished - 13 Nov 2019

Cite this